A study on overcoming the drug resistance to sarcoma
克服肉瘤耐药性的研究
基本信息
- 批准号:62570680
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this study the combined effect of anticancer agents and caffeine, which inhibits DNA repair, on human sarcomas was examined with various assay techniques. In human tumor clonogenic assay, the combined use of caffeine produced synergistic effects with four DNA-damaging agents (cisplatin, mitomycin C, cyclophosphamide and adriamycin). Particularly by the combination of cisplatin with caffeine, marked synergistic effects were observed in 14 out of 18 specimens (78%) of fresh human tumor specimens. Caffeine markedly increased the cytocidal effect of cisplatin following mitosis. At this time, the accumulation of S and G2/M phase was reduced on the DNA histogram, and nuclear fragmentations of tumor cells were frequently observed. In assay, using athymic mice, the combination of caffeine and cisplatin showed prominent antitumor effect without significant toxicity. These findings suggest the possibility that caffeine could be a useful drug capable of overcoming drug resistance to sarcomas, as caffeine enhanced the effect of DNA-damaging agents.
在这项研究中,抗癌药物和咖啡因,抑制DNA修复,对人类肉瘤的联合作用进行了研究与各种分析技术。在人肿瘤克隆形成实验中,咖啡因与顺铂、丝裂霉素C、环磷酰胺和阿霉素四种DNA损伤剂联合使用产生协同作用。特别是通过顺铂与咖啡因的组合,在18个新鲜人肿瘤标本中的14个(78%)中观察到显著的协同效应。有丝分裂后,咖啡因显著增加顺铂的杀细胞作用。此时,在DNA直方图上S和G2/M期的积累减少,并且经常观察到肿瘤细胞的核碎片。在实验中,采用无胸腺小鼠,咖啡因和顺铂的组合显示出显着的抗肿瘤作用,而没有显着的毒性。这些发现表明,咖啡因可能是一种有用的药物,能够克服肉瘤的耐药性,因为咖啡因增强了DNA损伤剂的作用。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tomita K and Tsuchiya H: "The combined effect of anticancer agents with caffeine on S-180 cells using flow cytometry technique" Oncologia. 21. 78-85 (1988)
Tomita K 和 Tsuchiya H:“使用流式细胞术技术观察抗癌剂与咖啡因对 S-180 细胞的联合作用”Oncologia。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katsuro Tomita: "Caffeine enhancement of the effect of anticancer agents on human sarcomd cells." Jpn.J.Cancer Res.80. 83-88 (1989)
Katsuro Tomita:“咖啡因增强抗癌剂对人类肉瘤细胞的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
土屋弘行: "ヒト肉腫培養細胞におけるシスプラチンとカフェインの併用効果" 癌と化学療法. 14. 3125-3130 (1987)
Hiroyuki Tsuchiya:“联合使用顺铂和咖啡因对培养的人类肉瘤细胞的影响”《癌症与化疗》14. 3125-3130 (1987)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katsuro Tomita: "Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma" Clinical Therapeutics. 11. 43-52 (1989)
Katsuro Tomita:“咖啡因在人骨肉瘤中增强顺铂的杀细胞和抗肿瘤作用”临床治疗。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOMITA Katsuro其他文献
TOMITA Katsuro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOMITA Katsuro', 18)}}的其他基金
Post longitudinal extension of spinal cord injury in spinal and section and contusion
脊髓损伤后纵向延伸、切片和挫伤
- 批准号:
18591625 - 财政年份:2006
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interruption of the bilateral segmental arteries at several levels : Influence on vertebral blood flow
双侧节段动脉多级阻断:对椎骨血流的影响
- 批准号:
13671498 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An experimental study on the influence of spinal shortening on the spinal cord
脊柱缩短对脊髓影响的实验研究
- 批准号:
11671425 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Physiological analysis of pelvic and epidural plexus veins in rabbits
家兔盆腔和硬膜外丛静脉的生理分析
- 批准号:
09671478 - 财政年份:1997
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of MTT Assay for Bone and Soft Tissue Tumor
骨与软组织肿瘤MTT检测研究
- 批准号:
01480365 - 财政年份:1989
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Research Grant
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
- 批准号:
10643423 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
- 批准号:
10713648 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
- 批准号:
10750627 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
利用可点击的抗体对逆转肿瘤的耐药性
- 批准号:
10566266 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Mathematical Modeling of Drug Resistance Evolution and The Optimal Treatment Strategy in EGFR Mutated Lung Cancer
EGFR突变肺癌耐药演化的数学模型及最佳治疗策略
- 批准号:
22KJ0768 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of prion strain-specific effect of antiprion drugs and drug resistance mechanisms
阐明抗朊病毒药物的朊病毒株特异性作用和耐药机制
- 批准号:
23H02828 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
靶向肿瘤和 TME 中的 RAGE,对抗肥胖相关 ER 乳腺癌的炎症和耐药性
- 批准号:
10734834 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Targeting chromosomal insatiability for overcoming drug resistance
针对染色体不饱和性克服耐药性
- 批准号:
23K08200 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)